Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Orally Bioavailable Endochin-like Quinolone Carbonate Ester Prodrug Reduces Toxoplasma gondii Brain Cysts

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.19.999664Source: DataRank Database

Orally Bioavailable Endochin-like Quinolone Carbonate Ester Prodrug Reduces Toxoplasma gondii Brain Cysts is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (24)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Tracey L. Schultz ORCID,Alyssa J. Miller ORCID,Igor Bruzual ORCID,Sovitj Pou,Rolf W. Winter

Live enrichment

PubMed:19910364 OpenAlex:https://openalex.org/W3011550766

National Institutes of Health

Grant: 5R01AI100569-06

Development of a Synergistic Drug Combination for Prevention and Treatment of Malaria

National Institutes of Health

Grant: 5R01AI100569-12

Novel Therapeutics to Target Parasite Cytochrome bc1

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2020/03/20/2020.03.19.999664.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.03.19.999664

repositoryhttps://doi.org/10.1101/2020.03.19.999664

https://aac.asm.org/content/aac/64/9/e00535-20.full.pdf

Fields of Study

Toxoplasma gondii Research StudiesHerpesvirus Infections and TreatmentsParasitic Infections and Diagnostics0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

BioavailabilityProdrugToxoplasma gondiiPharmacologyOral administrationToxoplasmosisPyrimethamineBiologyImmunologyMiceToxoplasmosis, AnimalCarbonatesAnimalsBrainEstersProdrugsQuinolonesToxoplasma

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being